References

Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention

10.1016/j.addr.2020.07.013 · 2020 · External reference

Cholesterol and prostate cancer

10.1016/j.coph.2012.07.006 · 2012 · External reference

Do the cholesterol-lowering properties of statins affect cancer risk?

10.1016/j.tem.2007.12.004 · 2008 · External reference

Lipid-lowering drug use and cancer incidence and mortality in the ARIC study

10.1093/jncics/pkab080 · 2021 · External reference

Sphingolipids and lipoproteins in health and metabolic disorders

10.1016/j.tem.2017.03.005 · 2017 · External reference

Sphingolipid metabolism in cancer signalling and therapy

10.1038/nrc.2017.96 · 2018 · External reference

Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: an observational study

10.1371/journal.pone.0216213 · 2019 · External reference

Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species

10.1111/acel.12369 · 2015 · External reference

Sphingosine-1-phosphate: an enigmatic signalling lipid

10.1038/nrm1103 · 2003 · External reference

Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways

10.1042/bst0311216 · 2003 · External reference

Role of ceramidases in sphingolipid metabolism and human diseases

10.3390/cells8121573 · 2019 · External reference

Bioactive sphingolipids as biomarkers predictive of disease severity and treatment response in cancer: current status and translational challenges

10.21873/anticanres.13078 · 2019 · External reference

Ceramide triggers budding of exosome vesicles into multivesicular endosomes

10.1126/science.1153124 · 2008 · External reference

Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis

10.1038/ncomms7956 · 2015 · External reference

Genome-wide in vivo screen identifies novel host regulators of metastatic colonization

10.1038/nature20792 · 2017 · External reference

Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis

10.1016/j.celrep.2022.111742 · 2022 · External reference

NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways

10.1016/j.abb.2019.02.008 · 2019 · External reference

The role of NOD-like receptors in innate immunity

10.3389/fimmu.2023.1122586 · 2023 · External reference

Sphingolipid metabolism and complement signaling in cancer progression

10.1016/j.trecan.2023.07.001 · 2023 · External reference

Modulation of the antitumor immune response by complement

10.1038/ni.1655 · 2008 · External reference

Context-dependent roles of complement in cancer

10.1038/s41568-019-0210-0 · 2019 · External reference

Dietary patterns, ceramide ratios, and risk of all-cause and cause-specific mortality: the Framingham Offspring Study

10.1093/jn/nxaa269 · 2020 · External reference

Plasma sphingolipids and lung cancer: a population-based, nested case-control study

10.1158/1055-9965.epi-12-1424 · 2013 · External reference

Enhancing the infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for cancer epidemiology research: ARIC cancer

10.1158/1055-9965.epi-17-0696 · 2018 · External reference

Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk

10.1038/s43587-021-00064-0 · 2021 · External reference

Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study

10.1161/01.atv.14.7.1098 · 1994 · External reference

Sphingolipid synthetic pathways are major regulators of lipid homeostasis

10.1007/978-1-4614-0650-1_9 · 2011 · External reference

Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis

10.1002/emmm.201200244 · 2012 · External reference

NLRP3 inflammasome in cancer and metabolic diseases

10.1038/s41590-021-00886-5 · 2021 · External reference